Retour
28
Fourchette du Jour
187,18 €
191,40 €
Fourchette 52 Semaines
152,33 €
246,33 €
Volume
552 187
Moyenne 50J / 200J
207,33 €
/
200,41 €
Clôture Précédente
185,82 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 8,0 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,8 |
| Net Margin % | 8,6 | 3,9 |
| Rev Growth 5Y % | 8,3 | 10,0 |
| D/E | — | 0,2 |
Points Clés
Revenue grew 8,26% annually over 5 years — modest growth
Earnings grew 30,36% over the past year
Generating 849,25M in free cash flow
P/E of 8,03 — trading at a low valuation
PEG of 0,26 suggests growth is underpriced
Capital efficient — spends only 5,85% of revenue on capex
Croissance
Revenue Growth (5Y)
8,26%
Revenue (1Y)9,71%
Earnings (1Y)30,36%
FCF Growth (3Y)27,22%
Qualité
Return on Equity
N/A
ROICN/A
Net Margin8,57%
Op. Margin11,48%
Sécurité
Debt / Equity
N/A
Current RatioN/A
Interest Coverage12,68
Valorisation
P/E Ratio
8,03
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 9,71% | Revenue Growth (3Y) | 10,27% |
| Earnings Growth (1Y) | 30,36% | Earnings Growth (3Y) | 44,02% |
| Revenue Growth (5Y) | 8,26% | Earnings Growth (5Y) | 10,69% |
| Profitability | |||
| Revenue (TTM) | 17,36B | Net Income (TTM) | 1,49B |
| ROE | N/A | ROA | N/A |
| Gross Margin | 90,45% | Operating Margin | 11,48% |
| Net Margin | 8,57% | Free Cash Flow (TTM) | 849,25M |
| ROIC | N/A | FCF Growth (3Y) | 27,22% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | 12,68 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 8,03 | P/B Ratio | N/A |
| P/S Ratio | 0,69 | PEG Ratio | 0,26 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 11,96B | Enterprise Value | N/A |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17,36B | 15,83B | 14,28B | 13,40B | 12,64B |
| Net Income | 1,49B | 1,14B | 717,80M | 675,61M | 991,59M |
| EPS (Diluted) | 23,10 | 16,82 | 10,23 | 9,14 | 11,82 |
| Gross Profit | 15,71B | 14,24B | 12,75B | 11,93B | 11,21B |
| Operating Income | 1,99B | 1,68B | 1,18B | 1,00B | 1,36B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#383 of 614
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026